| Dr Jafar Riad Hashem, MD | |
|
1509 Doctors Cir Bldg C, Wilmington, NC 28401-7403 | |
| (910) 662-7500 | |
| (910) 662-7501 |
| Full Name | Dr Jafar Riad Hashem |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 10 Years |
| Location | 1509 Doctors Cir Bldg C, Wilmington, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861854325 | NPI | - | NPPES |
| 200084877 | Medicaid | MO |
| Facility Name | Location | Facility Type |
|---|---|---|
| New Hanover Regional Medical Center | Wilmington, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Novant Health Medical Group Coastal Region Llc | 2860809936 | 412 |
News Archive
ADVENTRX Pharmaceuticals, Inc. announced today that it received a refuse to file letter from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for ANX-530 (vinorelbine injectable emulsion). In the letter, the FDA indicated that the data included in the initial submission from the intended commercial manufacturing site was insufficient to support a commercially-viable expiration dating period. FDA identified only the one chemistry, manufacturing and controls (CMC) reason for the refusal to file. ADVENTRX plans to meet with the FDA as soon as possible to discuss its response.
In their November issue, the Aesthetic Surgery Journal published a new breakthrough facelifting technique which gives superior results with fewer complications than current techniques in practice. The pioneer of this new Minimal Access Deep Plane Extended Vertical "MADE" Facelift is NY Facial Plastic and Reconstructive Surgeon, Dr. Andrew Jacono.
On February 11, 2005, the New York City Department of Health and Mental Hygiene (DOHMH) reported a case of HIV infection with a strain that is resistant to many drugs in three classes of HIV medications, and which appears to have progressed to AIDS within 4 to 20 months after infection.
While obesity significantly increases your chances of developing heart failure, for those with established heart failure it may confer a survival benefit compared with normal weight or underweight individuals, a new paper by researchers from the University of Adelaide reports.
› Verified 8 days ago
| Entity Name | Novant Health Medical Group Coastal Region Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649865791 PECOS PAC ID: 2860809936 Enrollment ID: O20210408000285 |
News Archive
ADVENTRX Pharmaceuticals, Inc. announced today that it received a refuse to file letter from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for ANX-530 (vinorelbine injectable emulsion). In the letter, the FDA indicated that the data included in the initial submission from the intended commercial manufacturing site was insufficient to support a commercially-viable expiration dating period. FDA identified only the one chemistry, manufacturing and controls (CMC) reason for the refusal to file. ADVENTRX plans to meet with the FDA as soon as possible to discuss its response.
In their November issue, the Aesthetic Surgery Journal published a new breakthrough facelifting technique which gives superior results with fewer complications than current techniques in practice. The pioneer of this new Minimal Access Deep Plane Extended Vertical "MADE" Facelift is NY Facial Plastic and Reconstructive Surgeon, Dr. Andrew Jacono.
On February 11, 2005, the New York City Department of Health and Mental Hygiene (DOHMH) reported a case of HIV infection with a strain that is resistant to many drugs in three classes of HIV medications, and which appears to have progressed to AIDS within 4 to 20 months after infection.
While obesity significantly increases your chances of developing heart failure, for those with established heart failure it may confer a survival benefit compared with normal weight or underweight individuals, a new paper by researchers from the University of Adelaide reports.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jafar Riad Hashem, MD Po Box 936857, Atlanta, GA 31193-6857 Ph: (910) 662-7500 | Dr Jafar Riad Hashem, MD 1509 Doctors Cir Bldg C, Wilmington, NC 28401-7403 Ph: (910) 662-7500 |
News Archive
ADVENTRX Pharmaceuticals, Inc. announced today that it received a refuse to file letter from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for ANX-530 (vinorelbine injectable emulsion). In the letter, the FDA indicated that the data included in the initial submission from the intended commercial manufacturing site was insufficient to support a commercially-viable expiration dating period. FDA identified only the one chemistry, manufacturing and controls (CMC) reason for the refusal to file. ADVENTRX plans to meet with the FDA as soon as possible to discuss its response.
In their November issue, the Aesthetic Surgery Journal published a new breakthrough facelifting technique which gives superior results with fewer complications than current techniques in practice. The pioneer of this new Minimal Access Deep Plane Extended Vertical "MADE" Facelift is NY Facial Plastic and Reconstructive Surgeon, Dr. Andrew Jacono.
On February 11, 2005, the New York City Department of Health and Mental Hygiene (DOHMH) reported a case of HIV infection with a strain that is resistant to many drugs in three classes of HIV medications, and which appears to have progressed to AIDS within 4 to 20 months after infection.
While obesity significantly increases your chances of developing heart failure, for those with established heart failure it may confer a survival benefit compared with normal weight or underweight individuals, a new paper by researchers from the University of Adelaide reports.
› Verified 8 days ago
Dr. James Perry Mayo Iii, M.D., MPH Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1426 Navaho Trl Unit 107, Wilmington, NC 28409 Phone: 910-518-8807 Fax: 910-216-4278 | |
Dr. Christopher Robert Myers, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3208 Oleander Dr, Wilmington, NC 28403 Phone: 910-794-3929 Fax: 910-798-2303 | |
Dr. Lionel Gregory Fernando, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 5617 Maxwell Pl, Wilmington, NC 28409 Phone: 910-742-9243 Fax: 888-746-1787 | |
Nina Leah Yokochi-funkhouser, DO Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2131 S 17th St, Wilmington, NC 28401 Phone: 910-815-5830 | |
Chih-cheng Frank Chen, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1608 Wellington Avenue, Wilmington Neurology Clinic, Wilmington, NC 28401 Phone: 910-395-5521 Fax: 910-350-1123 | |
Dr. Burt Powers Johnson, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2023 S 17th St, Wilmington, NC 28401 Phone: 910-251-6499 Fax: 910-251-6511 | |
Dr. Brett A Gurkin, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3208 Oleander Dr, Wilmington, NC 28403 Phone: 910-794-3929 Fax: 910-798-2303 |